Clinical Trial Update: Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating antigen-specific cytotoxic T cells for treating opportunistic infections including EBV, CMV, adenovirus, BK virus, fungal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• Cmv Infection
• Ebv Infection
• Fungal Infection
• Pathogen Infection
• Tuberculosis

Drugs mentioned

• Antigen-specific Cytotoxic T Cells (antigen-specific cytotoxic T cells)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Pathogen Infection, EBV Infection | Phase 1, Phase 2 | Status: UNKNOWN